HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1518649Generated: October 26, 2026
Diisopropylamine → Hexyl 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylate
https://huagongshe.com/reaction/1518649
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diisopropylamine | HCID 7912 | — |
| Reactant | Hexyl chloroformate | HCID 22466 | — |
| Reactant | Aripiprazole | HCID 60795 | — |
| Reactant | Butyllithium | HCID 178418339 | — |
| Solvent | 2-Methyltetrahydrofuran | HCID 7301 | — |
| Product | Hexyl 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylate | HCID 56596929 | — |
Reaction Steps
To a solution of diisopropylamine (1.11 mL, 7.87 mmol) in 2-methyltetrahydrofuran (37 mL) at −5° C. was added n-BuLi (3.0 mL, 2.5 M in hexanes, 7.49 mmol) slowly. After 20 minutes, the reaction was cooled to −78° C. and Aripiprazole (1.68 g, 3.74 mmol) was added. After a further 10 minutes, hexylchloroformate (1.53 mL, 9.37 mmol) was added. The reaction was held at −78° C. for 2 hours before allowing to warm to room temperature overnight. The reaction was quenched with saturated aqueous ammonium chloride solution (30 mL) and extracted with ethyl acetate (2×30 mL). The organics were combined, washed with saturated aqueous sodium hydrogen carbonate solution (30 mL), brine (30 mL), dried over MgSO4 and concentrated. The crude product was purified by column chromatography on silica eluting with 0 to 3% tetrahydrofuran in ethyl acetate. The product was triturated in heptane to remove aliphatic impurities and then filtered and dried to afford Compound-59 (0.487 g) as a colorless solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09072788B2 |
|---|
| Source dataset | uspto-grants-2015_07 |
|---|
| ORD ID | ord-885bdeb1cb204d6a8d1df64ae87b5019 |
|---|
| Source note | uspto-grants-2015_07 |
|---|